Does ABALOPARATIDE Cause Injection site erythema? 361 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Injection site erythema have been filed in association with ABALOPARATIDE (Tymlos). This represents 1.6% of all adverse event reports for ABALOPARATIDE.
361
Reports of Injection site erythema with ABALOPARATIDE
1.6%
of all ABALOPARATIDE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site erythema From ABALOPARATIDE?
Of the 361 reports, 3 (0.8%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for ABALOPARATIDE.
What Other Side Effects Does ABALOPARATIDE Cause?
Headache (4,048)
Nausea (3,134)
Dizziness (3,005)
Fatigue (2,637)
Heart rate increased (2,092)
Palpitations (1,730)
Arthralgia (1,711)
Bone pain (1,360)
Back pain (1,229)
Pain (1,191)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which ABALOPARATIDE Alternatives Have Lower Injection site erythema Risk?
ABALOPARATIDE vs ABATACEPT
ABALOPARATIDE vs ABATACEPT SUBQ /ML
ABALOPARATIDE vs ABCIXIMAB
ABALOPARATIDE vs ABEMACICLIB
ABALOPARATIDE vs ABILIFY